Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userEfficacy Of Botulinum Toxin-A Versus Transcutaneous Electric Nerve Stimulation(Tens) In Treatment of Masticatory System : A Clinical study
دراسة سريرية لتأثير العلاج بالبوتوكس مقارنة مع العلاج بالتنبيه الكهربائي العصبي على العضلات الماضعة
1090
1 29
0
(
0
)
Authors
قصي ناصيف( باحث )
Created by
Shamra Editor
Ask ChatGPT about the research
يهدف هذا البحث معرفة فعالية البوتوكسي (Botulinum Toxin-A (BTX A علاج الإصابات العضلية ،المندرجة تحت مسمى الاضطرابات الفكية الصدغية (Tempormandibular Disorders (TMD مقارنة مع العلاج بالتنبيو الكهربائي العصبي تحت الجلد (Transcutaneous Electrical Nerve Stimulation (TENS تم تقسيم عشرين مريض يعاني من الTMD إلى مجموعتين ، تم علاج المجموعة الأولى بحقن البوتوكس بمقدار 20 وحدة دولية في العضلة الماضغة و 20 وحدة دولية في العضلة الصدغية في الجهتين ، أما المجموعة الثانية و هي عشر مرضى تم علاجهم بال TENS, حيث طبقت المجسات على العضلتين الماضغة و الصدغية في الجهتين ، و ذلك لمدة 30 دقيقة في الجلسة و بمعدل 3 جلسات في الأسبوع و ذلك لمدة شهر . تم تسجيل مقدار الألم في العضلات الماضغة ) الماضغة و الصدغية ( عمى الجس وذلك قبل
The aim of this study was to evaluate the efficacy of botulinum toxin-A (BTX-A) therapy compared with Transcutaneous Electric Nerve Stimulation(TENS) in treatment against temporomandibular disorders clinically study Twenty patients with temporomandibular disorder symptoms and signs were enrolled in the study. The patients were randomly assigned into two groups. Patients in group 1 were injected with 20 IU BTX-A in the masseter and temporal muscle in both sides , whereas patients in group 2 were treated with (TENS),the electrodes were applied on masseter and temporal muscle in both sides, time of stimulation abut 30s ,3perweek for 4 week.
References used
Schwartz , J. Song, C . Blitzer, A 2007 - Oral Diseases ,pages 253–260
OHRBACH, R. STOHLER, CS- 1992- Review of the literature: a current diagnostic system, J CraniomandibDisord , 6: 307–317
Wijer, De. Leeuw, A. Steenks, JR. Bosnian, MH-1996- Temporomandibular and cervical spine disorders: self-reported signs and symptoms, Spine 21: 1638–1646
Artificial intelligence review:
Research summary
تهدف هذه الدراسة إلى تقييم فعالية العلاج بالبوتوكس (BTX-A) مقارنة مع العلاج بالتنبيه الكهربائي العصبي عبر الجلد (TENS) في علاج الاضطرابات الفكية الصدغية (TMD). تم تقسيم عشرين مريضًا يعانون من أعراض TMD إلى مجموعتين: مجموعة عولجت بحقن البوتوكس في العضلات الماضغة والصدغية، ومجموعة أخرى عولجت بالـ TENS. تم تقييم مستوى الألم قبل العلاج وبعد شهر وبعد ستة أشهر باستخدام مقياس من 0-3. أظهرت النتائج بعد شهر وجود فروق جوهرية بين الطريقتين لصالح البوتوكس، بينما لم تظهر فروق جوهرية بعد ستة أشهر. خلصت الدراسة إلى أن كلا الطريقتين فعالتين في العلاج العرضي لمدة تصل إلى ستة أشهر، مع تفوق البوتوكس في التأثير العلاجي السريع.
Critical review
دراسة نقدية: تعتبر هذه الدراسة خطوة مهمة في مقارنة فعالية طريقتين شائعتين لعلاج الاضطرابات الفكية الصدغية. ومع ذلك، يمكن توجيه بعض النقد البناء للدراسة. أولاً، حجم العينة صغير نسبيًا (20 مريضًا فقط)، مما قد يؤثر على تعميم النتائج. ثانيًا، لم يتم ذكر تفاصيل حول كيفية اختيار المرضى وتوزيعهم على المجموعتين، مما قد يثير تساؤلات حول العشوائية والتحيز. ثالثًا، لم يتم تناول الآثار الجانبية المحتملة لكل من البوتوكس وTENS بشكل كافٍ، وهو جانب مهم يجب مراعاته عند تقييم فعالية أي علاج. أخيرًا، كان من الأفضل تضمين مجموعة ضابطة لم تتلقَ أي علاج لمقارنة النتائج بشكل أكثر دقة.
Questions related to the research
-
ما هي الأهداف الرئيسية لهذه الدراسة؟
تهدف الدراسة إلى تقييم فعالية العلاج بالبوتوكس مقارنة مع العلاج بالتنبيه الكهربائي العصبي عبر الجلد في علاج الاضطرابات الفكية الصدغية.
-
كم عدد المرضى الذين شاركوا في الدراسة وكيف تم تقسيمهم؟
شارك في الدراسة عشرون مريضًا تم تقسيمهم إلى مجموعتين: مجموعة عولجت بحقن البوتوكس ومجموعة أخرى عولجت بالـ TENS.
-
ما هي النتائج الرئيسية التي توصلت إليها الدراسة بعد شهر من العلاج؟
أظهرت النتائج بعد شهر وجود فروق جوهرية بين الطريقتين لصالح البوتوكس.
-
هل كانت هناك فروق جوهرية بين الطريقتين بعد ستة أشهر من العلاج؟
لم تظهر فروق جوهرية بين الطريقتين بعد ستة أشهر من العلاج.
rate research
Read More
Objectives: This study aims to assess the efficacy of UVBnb phototherapy alone,
and with methotrexate in plaque psoriasis, and comparing the side effects and relapse
between the two kinds of treatments.
Study Design: randomized experimental study.
Methods: A total of 40 psoriasis patients were included in the study, 16 patients
were treated with UVBnb and methotrexate, whereas 24 patients were treated with
UVBnb alone. PASI was calculated for every patient every 2 weeks through treatment, and
every 4 weeks after clearance. Side effects and relapse were compared between two kinds
of therapy.
Results: there were no statistical important differences between two groups of study
according to clearance, clearance rate in combination group was 75% vs. 46% in
phototherapy group, tanning and hyperpigmentation were the most common side effects
for both groups, recurrence rate was 22.7% in study patients, all of them were from
phototherapy group.
Conclusion: this study revealed that UVBnb phototherapy alone,and with
methotrexate have the same efficacy in the treatment of psoriasis, and the combined
therapy with methotrexate reduce the number of UVBnb treatments necessary for
clearance. Side effects were tolerated in both kinds of treatments. Relapse after clearance
occurs more likely with alone UVBnb phototherapy.
Elastin and collagen loss from the dermal layer is essential cause for wrinkles in
the face. Dermal fillers is the solution for this problem and this study compared clinical improvement
degree and the duration of correction between hyaluronic acid (Matrigel) versus bovine collagen (Zyplast)
for the correction of nasolabial fold.
Objective: Keloid pose aesthetic and functional problems, in addition to being associated with disturbing clinical symptoms such as itching and pain, and current methods of treatment are limited in effectiveness. Clinical studies indicate that botuli
num toxin (BTA) may prevent the formation of keloid and treat it, so the aim of this research was to compare the effectiveness of topical injection of botulinum toxin versus topical steroid injection in the treatment of keloid. Methods: The research sample included 23 patients from the dermatology clinic at Tishreen University Hospital in Lattakia between 2019 and 2020, with keloids. The number of keloids registered with the studied sample was 30 distributed to two groups: Group A receiving IL steroid repeated every 4 weeks for six sessions, Group B IL BTA 5 IU /cm3 repeated every 8 weeks for three sessions. Objective parameters (hardness, elevation, pigmentation and vasscularity), subjective complaints (itching, pain, and tenderness), patient satisfaction, and side effects were evaluated. Results: There was a 58.4% decrease in the Vancouver scale for group A, and 65.8% for group B, without a statistical difference between the two groups (P <0.05). A noticeable decrease in tenderness 85.9% in treatment group A and 82.7% in treatment group B. A significant decrease in elevation in A 79.4% while B had a slight decrease of 27%. For vascularity we observed a slight decrease in treatment group A of 17.7% without statistical significance, whereas in treatment group B there was a decrease of 58%. The itching improvement in treatment group B was shown to be greater with statistically significant differences (P<0.05). Skin atrophy and telangiectasia were evident in 11 patients of group A. Conclusions: This study showed the efficacy and safety of topical toxin injection in treating keloid by improving objective and subjective criteria when compared to topical injection of corticosteroids. With fewer side effects reported for botulinum toxin.
furcation involvement occurs in the term of chronic periodontitis, and gives the
involved tooth worse prognosis, so that it represents a problem for diagnosis and treatment. The aim of
this study was to compare clinically the surgical treatment of
second degree- furcal involvement in
mandiblur molars (that each of them has one furcation), using Er:YAG laser versus conventional surgery.
The research aims to make a statistical approach to the cases of esophageal atresia by
its types and incidence, and to study the surgical treatment outcome and choose the best
method of treatment and follow up.
The study included 27 newborn patien
ts admitted in the Neonatal Intensive Care Unit
at Al-Assad University Hospital and Tishreen University Hospital in Lattakia, due to
diagnosis of esophageal atresia or tracheoesophageal fistula, from the beginning of January
2010 until the end of 2015. 14 of patients were males and 13 were females. Gross
classification of esophageal atresia was used, type (C) was found in 21 cases, type (A) was
found in 4 cases, type (E) was found in 2 cases, while type (B) and (D) were not seen. We
studied The clinical symptoms in newborn patients with this malformation, radial and
laboratory findings and associated malformations. We used esophageal contrast study
insure the diagnosis when needed. With type (C), we did primary anastomosis in 20 cases
and cervical esophagostomy with gastrostomy in only 1 case. With type (A), we did
esophagostomy with gastrostomy in all cases. With type (E), we closed the fistula with
cervical approach in all cases. The survival rate was 70.4%. Spitz classification was used
for risk assessment. The incidence of complications included anastomotic leakage 30% and
anastomotic stricture 69.2%.
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
